Julia Aulin
Researcher at Uppsala kliniska forskningscentrum (UCR)
- E-mail:
- julia.aulin@ucr.uu.se
- Visiting address:
- Dag Hammarskjölds väg 38
- Postal address:
- Uppsala Science Park
Dag Hammarskjölds väg 38
751 85 UPPSALA
Download contact information for Julia Aulin at Uppsala kliniska forskningscentrum (UCR)
Researcher at Institutionen för medicinska vetenskaper; Kardiologi
- E-mail:
- julia.aulin@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Download contact information for Julia Aulin at Institutionen för medicinska vetenskaper; Kardiologi
More information is available to staff who log in.
Short presentation
MD, PhD.
Publications
Selection of publications
- Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model (2022)
- Serum Neurofilament Light Chain in Patients With Atrial Fibrillation (2022)
- Biomarkers of inflammation in atrial fibrillation (2021)
- Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation (2020)
- Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers (2018)
- Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation (2016)
- Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation (2015)
Recent publications
- Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model (2022)
- Serum Neurofilament Light Chain in Patients With Atrial Fibrillation (2022)
- Biomarkers of inflammation in atrial fibrillation (2021)
- Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation (2020)
- Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers (2018)
All publications
Articles
- Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model (2022)
- Serum Neurofilament Light Chain in Patients With Atrial Fibrillation (2022)
- Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation (2020)
- Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers (2018)
- Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation (2016)
- Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation (2015)
- Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation (2014)
- Biomarkers predict risk for heart failure in patients with atrial fibrillation: Insights from the ARISTOTLE trial